Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/14/2026

Diagnosis and Management of Suspected Venous Thromboembolism in Pregnancy

1. Diagnostic Algorithm

  • A negative D‑dimer test in early pregnancy may lower the likelihood of VTE, but it must never be used as the sole rule‑out tool; clinicians should proceed immediately to bilateral compression ultrasonography, and if the scan is positive for deep‑vein thrombosis (DVT), therapeutic low‑molecular‑weight heparin (LMWH) should be started without further testing. 1
  • D‑dimer concentrations rise physiologically by ≈ 39 % each trimester, rendering the standard 0.50 mg/L cutoff ineffective by the third trimester. Mean values are 0.58 mg/L (first trimester), 0.83 mg/L (second trimester), and 1.16 mg/L (third trimester). By the third trimester, 99–100 % of healthy pregnant individuals exceed the 0.50 mg/L threshold. 1
  • If a D‑dimer is performed in early pregnancy and returns negative, VTE is less likely but cannot be excluded; imaging should still be obtained when clinical suspicion persists. 1
  • When D‑dimer is positive or not performed, clinicians should advance directly to imaging. 1
  • Bilateral compression ultrasonography is the recommended first‑line imaging modality for suspected DVT in pregnancy; it supersedes reliance on D‑dimer results. 1
  • A positive compression ultrasound mandates immediate therapeutic anticoagulation without additional confirmatory testing. 1
  • If the ultrasound is negative but D‑dimer is elevated or clinical suspicion remains high, further imaging for pulmonary embolism (PE) should be pursued. 1

2. Imaging for Suspected Pulmonary Embolism

  • Computed tomography pulmonary angiography (CTPA) is preferred over ventilation‑perfusion (V/Q) scanning because it delivers a lower fetal radiation dose (approximately 13–300 µGy depending on gestational age) compared with higher doses from V/Q scans. [2][1]
  • Magnetic resonance imaging (MRI) is an alternative that involves no ionizing radiation and provides high sensitivity and specificity for iliac‑vein thrombosis. 1
  • All radiation doses from diagnostic imaging in pregnancy remain far below the 50,000 µGy threshold considered hazardous to the fetus. 2

3. Anticoagulation Management

  • Therapeutic LMWH should be initiated immediately in any of the following situations: (a) positive compression ultrasound confirming DVT, (b) imaging‑confirmed PE, or (c) high clinical suspicion while awaiting definitive imaging. 1
  • LMWH dosing is weight‑based and administered twice daily. Dalteparin is commonly prescribed at 100 IU/kg twice daily. 2
  • The minimum duration of anticoagulation is three months or at least six weeks postpartum, whichever is longer. [2][1]

4. Safety and Pitfalls

  • Unfractionated heparin should not be used as first‑line therapy; LMWH is superior, associated with markedly lower rates of heparin‑induced thrombocytopenia and a very low incidence of osteoporosis (≈ 0.04 %). [2][1]
  • Warfarin must be avoided during the first trimester because it crosses the placenta and can cause embryopathy; LMWH does not cross the placenta and is safe throughout pregnancy. [2][1]
  • Clinicians must not rely on a normal D‑dimer alone to exclude VTE in the second or third trimester, as the false‑negative rate is unacceptably high due to physiologically elevated baseline levels. (Evidence based on cited data on trimester‑specific D‑dimer elevations.) 1
  • Imaging should not be delayed while awaiting D‑dimer results when clinical suspicion is moderate to high; compression ultrasonography should be performed promptly. 1

Management of Elevated D-dimer in Pregnant Women

Understanding D-dimer in Pregnancy

  • D-dimer levels increase progressively throughout pregnancy, with approximately 39% relative increase in each trimester compared to the previous one 3
  • Mean D-dimer concentrations during pregnancy are as follows:

    Trimester D-dimer Concentration
    First trimester 0.58 mg/L [3]
    Second trimester 0.83 mg/L [3]
    Third trimester 1.16 mg/L [3]

    Diagnostic Algorithm for Suspected VTE with Elevated D-dimer

  • The European Society of Cardiology recommends that despite limitations, a negative D-dimer still has some exclusion value, particularly in early pregnancy 4
  • If D-dimer is elevated, the American College of Chest Physicians recommends proceeding with bilateral compression ultrasonography 3, 4
  • If ultrasound is positive for DVT, the European Society of Cardiology recommends initiating anticoagulation treatment 3, 4
  • If ultrasound is negative but clinical suspicion for PE remains, the American Thoracic Society recommends further imaging 3, 5

Treatment When VTE is Confirmed

  • The American College of Cardiology recommends low molecular weight heparin (LMWH) as the drug of choice for treatment of VTE in pregnancy 3, 5, 6
  • The European Society of Cardiology recommends dosing LMWH based on weight, with enoxaparin at 1 mg/kg body weight twice daily 6 and dalteparin at 100 IU/kg body weight twice daily 5, 6
  • The American College of Chest Physicians recommends targeting 4-6 hour peak anti-Xa values of 0.6-1.2 IU/mL 5

Prophylaxis Based on Risk Assessment

  • For high-risk women, the American College of Obstetricians and Gynecologists recommends antenatal prophylaxis with LMWH and continuing prophylaxis for 6 weeks postpartum 6
  • For intermediate-risk women, the European Society of Cardiology recommends considering antenatal prophylaxis with LMWH and prophylaxis for at least 7 days postpartum 6
  • For low-risk women, the American College of Physicians recommends early mobilization and avoiding dehydration 6, 3, 7

Important Caveats

  • The American Thoracic Society/Society of Thoracic Radiology explicitly recommends against using D-dimer alone to exclude PE in pregnancy due to low specificity (15%) 4

Imaging Strategy for Suspected Venous Thromboembolism in Pregnancy

General Imaging Recommendations

  • The American Society of Hematology and the American College of Chest Physicians advise that, at 16 weeks gestation, an elevated D‑dimer provides minimal diagnostic value and imaging should not be delayed while awaiting or interpreting D‑dimer results when clinical suspicion exists. [8][9]

Lower‑Extremity Ultrasound Protocol

  • Perform a bilateral proximal compression ultrasound that includes the common femoral and popliteal veins together with Doppler assessment of the iliac veins in a single examination. [8][9]
  • If the initial proximal compression ultrasound is negative but clinical suspicion persists or the D‑dimer is markedly elevated, repeat the proximal compression ultrasound on day 3 and day 7. [8][9]

Special Consideration: Suspected Iliac Vein Thrombosis

  • In patients with whole‑leg swelling or flank, buttock, or back pain and a negative standard proximal ultrasound, obtain a Doppler ultrasound of the iliac vein or a magnetic resonance venography without gadolinium to evaluate for iliac vein thrombosis. [8][9]

Evaluation for Pulmonary Embolism

  • When lower‑extremity ultrasound is negative but the patient exhibits respiratory symptoms or the overall clinical picture suggests pulmonary embolism, proceed promptly to chest imaging. 10
  • Recent evidence from the American Thoracic Society and the Society of Thoracic Radiology now favors computed tomography pulmonary angiography (CTPA) over ventilation‑perfusion (V/Q) scanning because CTPA provides superior diagnostic accuracy and delivers lower fetal radiation exposure (approximately 13–300 µGy, well below the 50,000 µGy safety threshold). [10][8]
  • Routine initial testing should not include whole‑leg ultrasound; a proximal compression ultrasound with iliac Doppler is sufficient and reduces false‑positive findings from incidental calf‑vein thromboses. 9

Diagnostic and Management Recommendations for Suspected Pulmonary Embolism in Pregnancy

Diagnostic Imaging Algorithm

  • Perform bilateral compression ultrasonography of the lower extremities (including Doppler assessment of the iliac veins) as the first‑line imaging test in pregnant patients with moderate‑to‑high suspicion of PE. This approach allows rapid detection of DVT and guides immediate therapy. 11

  • If compression ultrasonography identifies a DVT, initiate therapeutic low‑molecular‑weight heparin (LMWH) without proceeding to further pulmonary imaging. The presence of DVT alone warrants anticoagulation regardless of concurrent PE. 11

  • When the lower‑extremity ultrasound is negative but clinical suspicion remains high, obtain a chest radiograph to triage subsequent imaging. The chest X‑ray is the first radiation‑associated procedure and helps decide between V/Q scintigraphy and CTPA. 11

  • If the chest X‑ray is normal, prefer ventilation‑perfusion (V/Q) lung scintigraphy over computed tomography pulmonary angiography (CTPA) because V/Q delivers substantially lower maternal radiation exposure (≈0.98–1.07 mGy vs. 10–60 mGy with CTPA). 11

  • If the chest X‑ray shows abnormalities, proceed directly to CTPA to maximize diagnostic yield and to identify alternative thoracic pathology. 11

  • When a V/Q scan is nondiagnostic, follow up with CTPA to achieve definitive diagnosis and avoid missing a potentially fatal PE. 11

  • In cases of whole‑leg swelling or buttock/groin/flank/abdominal pain with a negative standard compression study, obtain Doppler ultrasound of the iliac veins or MRI venography to evaluate for iliac vein thrombosis, which is more common on the left side in pregnancy due to uterine compression. 12

Clinical Assessment Pitfalls

  • Do not attribute severe dyspnea and marked functional limitation (e.g., inability to walk more than half a block) to “normal pregnancy breathlessness.” Such symptoms indicate a high pre‑test probability of PE and require urgent work‑up. 12

  • Clinical prediction scores such as PESI or sPESI are not reliable in pregnancy because physiologic changes (lower blood pressure, higher heart rate, baseline dyspnea) distort the scoring variables. Therefore, they should not be used to stratify risk in pregnant patients. 13

Anticoagulation Management

  • Low‑molecular‑weight heparin (LMWH) is the only anticoagulant considered safe for both mother and fetus; direct oral anticoagulants (DOACs) and warfarin must be avoided because they cross the placenta and can cause fetal harm. 13

Multidisciplinary Coordination

  • All pregnant patients with suspected or confirmed PE should receive a formal obstetrics consultation before discharge, with documented responsibility for ongoing care and follow‑up. This ensures coordinated management of maternal and fetal health. 13

  • A multidisciplinary team review (including obstetrics, maternal‑fetal medicine, and pulmonary/vascular specialists) is recommended prior to any discharge decision for pregnant women with PE. 13

REFERENCES

4

D-dimer Interpretation in Pregnancy [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025